MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10840-023-01705-7

Медицинская библиотека · Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2023

Technological advances in ventricular tachycardia catheter ablation: the relentless quest for novel solutions to old problems.

Compagnucci Paolo, Valeri Yari, Conti Sergio, Volpato Giovanni, Cipolletta Laura, Parisi Quintino, D'Angelo Leonardo, Campanelli Francesca, Carboni Laura, Sgarito Giuseppe, Natale Andrea, Casella Michela, Dello Russo Antonio

СтатьяОбзорКлинический случайПеревод в очереди

Аннотация

BACKGROUND

Several novel technologies allowing catheter ablation (CA) with a favorable safety/efficacy profile have been recently developed, but not yet extensively clinically tested in the setting of ventricular tachycardia CA.

METHODS

In this technical report, we overview technical aspects and preclinical/clinical information concerning the application of three novel CA technologies in the ventricular milieu: a pulsed field ablation (PFA) generator (CENTAURI™, Galaxy Medical) to be used with linear, contact force-sensing radiofrequency ablation catheters; a contact force-sensing radiofrequency ablation catheter equipped with six thermocouples and three microelectrodes (QDOT Micro™, Biosense-Webster), allowing high-resolution mapping and temperature-controlled CA; and a flexible and mesh-shaped irrigation tip, contact force-sensing radiofrequency ablation catheter (Tactiflex, Abbott). We also report three challenging VT cases in which CA was performed using these technologies.

RESULTS

The CENTAURI system was used with the Tacticath™ (Abbott) ablation catheter to perform ventricular PFA in a patient with advanced heart failure, electrical storm, and a deep intramural septal substrate. Microelectrode mapping using QDOT Micro™ helped to refine substrate assessment in a VT patient with congenitally corrected transposition of the great arteries, and allowed the identification of the critical components of the VT circuit, which were successfully ablated. Tactiflex™ was used in two challenging CA cases (one endocardial and one epicardial), allowing acute and mid-term control of VT episodes without adverse events.

CONCLUSION

The ideation and development of novel technologies initially intended to treat atrial arrhythmias and successfully implemented in the ventricular milieu is contributing to the progressive improvement in the clinical benefits derived from VT CA, making this procedure key for successful management of increasingly complex patients.

Для цитирования: Compagnucci Paolo, Valeri Yari, Conti Sergio, Volpato Giovanni, Cipolletta Laura, Parisi Quintino, D'Angelo Leonardo, Campanelli Francesca, Carboni Laura, Sgarito Giuseppe, Natale Andrea, Casella Michela, Dello Russo Antonio. Technological advances in ventricular tachycardia catheter ablation: the relentless quest for novel solutions to old problems.. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. 2023. DOI: 10.1007/s10840-023-01705-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.